RBM10通过抑制通过PD-1表达的免疫逃逸来抑制胰腺癌的发展
Xia Gao1,2, Xiuqin Zhang3, Junjie Huang1
1Department of Pathology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Journal of Cancer
|July 31, 2025
概括
通过抑制免疫逃逸,RNA结合动机蛋白-10 (RBM10) 抑制了胰腺癌的进展. 较低的RBM10水平促进瘤生长,并通过JAK-STAT信号传递减少自然杀手细胞的活动.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 胰腺腺癌 (PAAD) 是一种具有不良预后的侵袭性癌症.
- 在PAAD进展和免疫调节中RNA结合动机蛋白-10 (RBM10) 的作用尚未完全理解.
研究的目的:
- 研究RBM10在胰腺癌进展中的功能.
- 阐明RBM10影响瘤免疫微环境的机制.
主要方法:
- 西部涂抹,RT-qPCR和免疫组织化学,以评估PAAD组织中的RBM10表达.
- 在体外实验中,RBM10在胰腺癌细胞中被击倒.
- 生物信息分析以确定与RBM10相关的途径和免疫变化.
- 自然杀手 (NK) 细胞细胞毒性和PD-1表达的评估.
主要成果:
- 与非癌性组织相比,PAAD组织中的RBM10表达显着较低.
- 抗击RBM10增强了胰腺癌细胞的增殖,迁移和殖民地形成,与增加的P-JAK1,P-JAK2和P-STAT3.3相关.
- 癌细胞中的RBM10缺乏导致NK细胞中PD-1表达的增加,损害了它们杀伤瘤的能力.
- 抑制JAK通路 (AZD1480) 恢复了NK细胞的细胞毒性.
结论:
- RBM10通过抑制瘤免疫逃逸来抑制胰腺癌的进展.
- 在NK细胞中,RBM10通过JAK-STAT介导的PD-1表达的调节来发挥其功能.
- 在PAAD患者中,RBM10表达与良好的预后有关,这表明它有可能成为治疗点.
相关概念视频
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K


